JIC
BLUE

Johnson Investment Counsel’s bluebird bio BLUE Stock Holding History

Johnson Investment Counsel’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,187
Closed -$30.4K – 768
2024
Q1 		$30.4K Sell
1,187
-207
-15% -$5.31K ﹤0.01% 755
2023
Q4 		$38.5K Buy
1,394
+734
+111% +$44.8K ﹤0.01% 707
2023
Q3 		$40.2K Buy
+660
New +$46.4K ﹤0.01% 669

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Johnson Investment Counsel's BLUE Position: Q2 2024 in Review

Johnson Investment Counsel sold out of bluebird bio (BLUE) in Q2 2024, closing a stake of 1,187 shares — an estimated $30.4K sold.

Johnson Investment Counsel first reported a position in BLUE in Q3 2023 and held it in 3 quarters. The position peaked at $40.2K in Q3 2023. 150 funds tracked by Wall St. Rank hold BLUE as of Q2 2024.

  • Johnson Investment Counsel reported no remaining bluebird bio position as of Q2 2024 after selling out during the quarter.
  • Johnson Investment Counsel sold 1,187 bluebird bio shares in Q2 2024, an estimated $30.4K.
  • Johnson Investment Counsel first reported a position in bluebird bio in Q3 2023 and held it in 3 quarters.
  • Johnson Investment Counsel's bluebird bio position peaked at $40.2K in Q3 2023.
  • 150 funds tracked by Wall St. Rank held bluebird bio as of Q2 2024.

Based on Johnson Investment Counsel's 13F filing for Q2 2024, filed 8 Aug 2024.